ID

20448

Description

4-Week Lead-In With Nitazoxanide Followed by 36 Weeks Nitazoxanide and Peginterferon Alfa-2a in Chronic Hepatitis C; ODM derived from: https://clinicaltrials.gov/show/NCT00763568

Link

https://clinicaltrials.gov/show/NCT00763568

Keywords

  1. 2/22/17 2/22/17 -
Uploaded on

February 22, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Chronic Hepatitis C NCT00763568

Eligibility Chronic Hepatitis C NCT00763568

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
chronic hepatitis c
Description

chronic hepatitis c

Data type

boolean

Alias
UMLS CUI [1]
C0524910
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
previously failed to respond to at least 12 weeks of peginterferon plus ribavirin combination therapy.
Description

Combination peginterferon and ribavirin therapy prescribed (HEP-C); Absent response to treatment

Data type

boolean

Alias
UMLS CUI [1,1]
C1971490
UMLS CUI [1,2]
C0438286
unable to take oral medication.
Description

unable to take oral medication

Data type

boolean

Alias
UMLS CUI [1]
C2222393
females who are either pregnant, breast-feeding or not using birth control.
Description

pregnancy, breast feeding, contraceptive methods

Data type

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0006147
UMLS CUI [1,3]
C0700589
males whose female partners are pregnant or plan to become pregnant.
Description

partner pregnant, gender

Data type

boolean

Alias
UMLS CUI [1]
C0919624
UMLS CUI [2]
C0079399
other causes of liver disease (for example, autoimmune hepatitis, decompensated liver disease).
Description

Comorbidity; Liver diseases | Hepatitis, Autoimmune | Decompensated liver disease

Data type

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0023895
UMLS CUI [2]
C0241910
UMLS CUI [3]
C4075847
patients with hiv, hav, hbv or hdv.
Description

hiv, hbv, hav, hdv

Data type

boolean

Alias
UMLS CUI [1]
C0019682
UMLS CUI [2]
C0019163
UMLS CUI [3]
C0019159
UMLS CUI [4]
C0011226
patients with a history of alcoholism or with an alcohol consumption of more than 40 grams per day.
Description

Medical History; Substance Use Disorders; Alcohol consumption

Data type

boolean

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0038586
UMLS CUI [1,3]
C0001948
patients with hemoglobinopathies (for example, thalassemia major, sickle-cell anemia).
Description

Hemoglobinopathies | Thalassemia | Anemia, Sickle Cell

Data type

boolean

Alias
UMLS CUI [1]
C0019045
UMLS CUI [2]
C0039730
UMLS CUI [3]
C0002895
history of hypersensitivity or intolerance to nitazoxanide or peginterferon.
Description

hypersensitivity to nitazoxanide or peginterferon

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0068788
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0982327

Similar models

Eligibility Chronic Hepatitis C NCT00763568

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
chronic hepatitis c
Item
chronic hepatitis c
boolean
C0524910 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Combination peginterferon and ribavirin therapy prescribed (HEP-C); Absent response to treatment
Item
previously failed to respond to at least 12 weeks of peginterferon plus ribavirin combination therapy.
boolean
C1971490 (UMLS CUI [1,1])
C0438286 (UMLS CUI [1,2])
unable to take oral medication
Item
unable to take oral medication.
boolean
C2222393 (UMLS CUI [1])
pregnancy, breast feeding, contraceptive methods
Item
females who are either pregnant, breast-feeding or not using birth control.
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
C0700589 (UMLS CUI [1,3])
partner pregnant, gender
Item
males whose female partners are pregnant or plan to become pregnant.
boolean
C0919624 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
Comorbidity; Liver diseases | Hepatitis, Autoimmune | Decompensated liver disease
Item
other causes of liver disease (for example, autoimmune hepatitis, decompensated liver disease).
boolean
C0009488 (UMLS CUI [1,1])
C0023895 (UMLS CUI [1,2])
C0241910 (UMLS CUI [2])
C4075847 (UMLS CUI [3])
hiv, hbv, hav, hdv
Item
patients with hiv, hav, hbv or hdv.
boolean
C0019682 (UMLS CUI [1])
C0019163 (UMLS CUI [2])
C0019159 (UMLS CUI [3])
C0011226 (UMLS CUI [4])
Medical History; Substance Use Disorders; Alcohol consumption
Item
patients with a history of alcoholism or with an alcohol consumption of more than 40 grams per day.
boolean
C0262926 (UMLS CUI [1,1])
C0038586 (UMLS CUI [1,2])
C0001948 (UMLS CUI [1,3])
Hemoglobinopathies | Thalassemia | Anemia, Sickle Cell
Item
patients with hemoglobinopathies (for example, thalassemia major, sickle-cell anemia).
boolean
C0019045 (UMLS CUI [1])
C0039730 (UMLS CUI [2])
C0002895 (UMLS CUI [3])
hypersensitivity to nitazoxanide or peginterferon
Item
history of hypersensitivity or intolerance to nitazoxanide or peginterferon.
boolean
C0020517 (UMLS CUI [1,1])
C0068788 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0982327 (UMLS CUI [2,2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial